Among critically ill adults undergoing emergency tracheal intubation, one in five experience hypotension, cardiac arrest, or death. The sedatives used to rapidly induce anesthesia for emergency tracheal intubation have been hypothesized to effect cardiovascular complications and patient outcomes, but the optimal sedative medication for intubation of critically ill adults remains unknown. Ketamine and etomidate are the two most commonly used sedatives during intubation of critically ill adults. Data from a randomized clinical trial are urgently needed to determine the effect of ketamine versus etomidate on cardiovascular complications and clinical outcomes of emergency tracheal intubation.
Acute Respiratory Failure
Among critically ill adults undergoing emergency tracheal intubation, one in five experience hypotension, cardiac arrest, or death. The sedatives used to rapidly induce anesthesia for emergency tracheal intubation have been hypothesized to effect cardiovascular complications and patient outcomes, but the optimal sedative medication for intubation of critically ill adults remains unknown. Ketamine and etomidate are the two most commonly used sedatives during intubation of critically ill adults. Data from a randomized clinical trial are urgently needed to determine the effect of ketamine versus etomidate on cardiovascular complications and clinical outcomes of emergency tracheal intubation.
Randomized Trial of Sedative Choice for Intubation
-
UAB Hospital, Birmingham, Alabama, United States, 35233
University of Colorado Denver, Aurora, Colorado, United States, 80045
Denver Health Medical Center, Denver, Colorado, United States, 80204
Hennepin County Medical Center, Minneapolis, Minnesota, United States, 55415
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States, 27157
Vanderbilt University Medical Center, Nashville, Tennessee, United States, 37232
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Vanderbilt University Medical Center,
Jonathan D Casey, MD, MSc, PRINCIPAL_INVESTIGATOR, Vanderbilt University Medical Center
Matthew W Semler, MD, MSc, STUDY_CHAIR, Vanderbilt University Medical Center
Todd W Rice, MD, MSc, STUDY_DIRECTOR, Vanderbilt University Medical Center
Wesley H Self, MD, MPH, STUDY_DIRECTOR, Vanderbilt University Medical Center
2027-02-01